Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

After Phase III Hit With Strep Drug, Advancis Planning NDA

Aug. 11, 2006

By Jennifer Boggs

Neurochem Secures Funding Through $60M Credit Facility

Aug. 11, 2006

By Jennifer Boggs

Altor Moving To Clinic With T-Cell Receptor-Based Drug

Aug. 10, 2006

By Jennifer Boggs

Altor Moving To Clinic With T-Cell Receptor-Based Drug

Aug. 10, 2006

By Jennifer Boggs

Genizon Signs Genentech To Use Crohn's GeneMap

Aug. 9, 2006

By Jennifer Boggs

Genizon Signs Genentech To Use Crohn's GeneMap

Aug. 9, 2006

By Jennifer Boggs

Nanoemulsion Platform Gets $30M Financing For NanoBio

Aug. 8, 2006

By Jennifer Boggs

Nanoemulsion Platform Gets $30M Financing For NanoBio

Aug. 8, 2006

By Jennifer Boggs

PDL Reports Phase III Failure Of Terlipressin In Type I HRS

Aug. 7, 2006

By Jennifer Boggs

PDL Reports Phase III Failure Of Terlipressin In Type I HRS

Aug. 7, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...